Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 4Neoplasms 3Head and Neck Neoplasms 3Mucositis 2Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Multiple Myeloma 1Lymphoma 1Leukemia 1Laryngeal Diseases 1Cataract 1Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 4Cisplatin 3Cetuximab 2pembrolizumab 1monalizumab 1Tirapazamine 1Radiotherapy, Adjuvant 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Laryngectomy 1Fluorouracil 1Fibroblast Growth Factor 7 1Emulsions 1Docetaxel 1Chemoradiotherapy 1Bleomycin 1Allovectin-7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Laryngeal Diseases × Fibroblast Growth Factor 7 × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡